Relying on external labs for bacterial analysis, which takes 7+ days, manufacturing sites must sometimes discard goods, clean up, and reproduce, causing significant financial losses and production inefficiencies.
We enabled shifting analysis to manufacturing sites, opening doors for on-site testing within one day and reducing reliance on slow external labs. Our solution, a custom software designed for sequencing data interpretation by non-experts, streamlines decision-making and shortens the feedback loop.
This approach not only minimizes waste and reproduction in case of contamination but also improves the ability to identify and prevent future pollution sources, enhancing operational efficiency and risk management.
By reducing bacterial analysis times from over 7 days to just 1 hour, the solution streamlines production processes, enabling daily safety checks and potentially saving over 1000 operational hours annually. This efficiency gain allows for quicker product throughput and reduced risk of production stoppages.
The transition to on-site bacterial analysis conservatively estimates a 30-50% reduction in downtime costs by preventing delays that lead to significant financial losses. Assuming an average cost of $10,000 lost per day of production delay, the solution could save the company upwards of $70,000 for each avoided stoppage, enhancing overall productivity and profitability.
Implementing rapid bacterial analysis technology significantly mitigates the risk of production halts and delayed releases, ensuring continuous operation and maintaining supply chain integrity. Beyond immediate cost and time savings, this strategic shift secures the company's reputation for reliability and safety.
From advanced analytics to platform development and pharma consulting, we craft solutions tailored to your needs.
Talk to our Experts